Baylor College of Medicine: Research to Revenue

Baylor College of Medicine

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 7 commercialization opportunities from Baylor College of Medicine and scored them based on our proprietary metrics and rubrics.

The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.

Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation

150-179 Strong Innovation

130-149 Moderate Innovation

100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of Baylor College of Medicine's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

43/100

Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

8/100

Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

56/100

Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded

1900

First Nobel

2004

First Patent

1985

First IPO

N/A

2022-2024

Gene-editing therapy

2025

Today

Notable Commercialization Outcomes

Nobel Prizes

1969

First Patent

Isolation of human insulin gene

1969

Tech Transfer

Established technology licensing office

1980

Drug Development

Innovated cancer therapeutic agents

1990s

Genomic Research

Sequenced human genome segments

2000s

Startup Launch

Spun off biotech companies

2010s

Competitive Benchmarking

Baylor College of Medicine vs. Peer Research Universities

Baylor College of Medicine vs Peers Comparison

Metric	Baylor College of Medicine (FY2023)	Peer Average	Elite Average
Annual R&D Expenditure	$847M	$855M	$1,675M
New Inventions Disclosed	6	200	400
Startups Formed	3	7	10
Visibility Index	19	12	23
Licensing Revenue	$10M	$17M	$46M

Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. AI-Driven Precision Oncology Enhances Cancer Treatment Outcomes

AI-powered diagnostics improve accuracy in cancer detection, enabling personalized therapies that reduce mortality and healthcare costs across a growing oncology market.

2. Advanced Gene Editing Platforms Revolutionize Rare Disease Therapies

Cutting-edge CRISPR technologies offer scalable, targeted treatments for rare genetic disorders, addressing unmet medical needs with high commercial potential.

3. Novel Neuroprotective Biomaterials for Brain Injury Recovery

Innovative biomaterials promote neural regeneration post-injury, capturing a significant market in traumatic brain injury treatment and rehabilitation.

4. Next-Generation Immunotherapies Targeting Autoimmune Diseases

Breakthrough immune-modulating therapies provide safer, more effective treatments for autoimmune conditions, expanding scalable options in a large patient population.

5. Rapid Viral Diagnostics Accelerate Pandemic Response Capabilities

Point-of-care viral detection platforms enable quick outbreak containment, offering scalable solutions critical for global health security and infectious disease management.

6. Regenerative Medicine Technologies for Cardiac Repair

Stem cell-based therapies restore heart function post-myocardial infarction, addressing a leading cause of death with significant market demand and growth potential.